发明名称 PHARMACEUTICAL COMPOSITION COMPRISING OLMESARTAN MEDOXOMIL AND ROSUVASTATIN OR ITS SALT
摘要 <p>PURPOSE: A pharmaceutical composition is provided to resolve absorption suppression due to drug interaction by formulation of olmesartan medoxomil and rosuvastatin or a salt thereof. CONSTITUTION: A pharmaceutical composition comprises a fraction containing olmesartan medoxomil and a fraction containing rosuvastatin or a salt thereof. The fractions are formed in a single form. The pharmaceutical composition is manufactured in the form of a bilayer tablet, a cored tablet, or a pellet-containing capsule. The pharmaceutical composition is manufactured in a bilayer form comprising a layer containing rosuvastatin or a salt thereof and a layer containing olmesartan medoxomil. The pharmaceutical composition is manufactured in a capsule form comprising a pellet containing rosuvastatin or a salt thereof and a pellet containing olmesartan medoxomil. [Reference numerals] (AA) Olmesartan average concentration in blood (N=12); (BB) Control medicine; (CC) Test medicine</p>
申请公布号 KR20130111335(A) 申请公布日期 2013.10.10
申请号 KR20130030734 申请日期 2013.03.22
申请人 DAEWOONG PHARMACEUTICAL CO., LTD. 发明人 CHANG, HEE CHUL;KANG, BOK KI;KIM, JUN KU
分类号 A61K31/4178;A61K9/24;A61K9/48;A61K31/505 主分类号 A61K31/4178
代理机构 代理人
主权项
地址